A critical breakthrough in cancer study is arising with the use of mini-antibodies to reactivate dysfunctional p53. This crucial cancer suppressor protein is frequently lost in many kinds of cancer, resulting https://checkbookmarks.com/story7669459/nanobodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-malignant-therapy